Vedolizumab for the Treatment of Adults with Moderate-to-Severe Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Essat, Munira, Tappenden, Paul, Ren, Shijie, Bessey, Alice, Archer, Rachel, Wong, Ruth, Lobo, Alan, Hoque, SamiVolume:
34
Language:
english
Journal:
PharmacoEconomics
DOI:
10.1007/s40273-015-0334-3
Date:
March, 2016
File:
PDF, 521 KB
english, 2016